RNAte – Immune screening for future RNA medicines

Precision RNA testing: Ensuring efficiency in every strand

Recent advances in understanding synthetic RNA and its applications in medicine have increased the need for a robust and reliable screening platform to ensure successful transition of new RNA product into clinical trials.

Hudson Institute recognises this demand and is establishing RNAte, a specialised innate immune testing facility. RNAte plays a valuable role in assessing innate immune activation and cytokine signalling in response to novel RNA products, contributing to the development of safe and more effective RNA-based products for clinical trials.

Get in touch

Dr Garrett Ng in the RNAte lab conducting tests.

ABOUT RNAte

Unlocking the Potential of RNA Technologies

Our platform is designed to support the emerging RNA industry by providing meticulous analyses and readouts of the immune reactivity of newly developed RNA and mRNA therapeutics.

More about us

Supporting innovation in RNA technologies

With the rapid growth of RNA therapeutics and the complexities surrounding their interaction with the immune system, there’s an urgent need for a dedicated screening facility. RNAte addresses this crucial gap in the industry by offering high throughput immune screening, mitigating the risks associated with unwanted inflammatory responses and maximising the potential of RNA-based products.

Commitment to transitioning RNA products to clinical trials

At RNAte, our mission is to foster the development of safe and effective RNA-based therapeutics. By harnessing our expertise in innate immune pathways and screening capabilities, we are proud to facilitate the creation of groundbreaking treatments for a wide range of diseases, thereby contributing to the advancement of global healthcare.

Innate immune screening for cutting-edge drug development

RNAte offers an extensive suite of testing services encompassing key all innate immune and cytokine signalling pathways. Our platform is positioned to meet the growing demand for innovative therapeutics that target inflammatory pathways associated with chronic diseases. By providing thorough and reliable testing, we support academia and pharmaceutical companies in their pursuit of groundbreaking therapeutics targeting the innate immune system.

SERVICES

Unlocking the Power of RNA Medicines

The RNAte platform is designed to support the RNA industry by providing an accurate assessment of innate immune activation to inform product development and readiness for clinical trials.

Find out more

Dr Natália Sampaio pipetting in the RNAte lab